首页> 外文期刊>Chemical Weekly >Indian companies among firms yet to pay annual facility fees to FDA
【24h】

Indian companies among firms yet to pay annual facility fees to FDA

机译:印度公司中尚未向FDA支付年度设施费的公司

获取原文
获取原文并翻译 | 示例
           

摘要

The US-FDA has named at least five Indian companies, including Marck Biosciences and RPG Life Sciences, among 43 drugmakers that have failed to meet their annual facility fee payment obligations. The other Indian firms that have not satisfied their annual fee requirements under the Generic Drug User Fee Amendments (GDUFA) include Virupaksha Organics P. Ltd., Vista Pharmaceuticals Ltd. and Vital Laboratories P. Ltd.
机译:美国食品药品监督管理局已经指定了至少五家印度公司,其中包括马克生物科技公司和RPG生命科学公司,这些公司没有履行其年度设施费支付义务的43家制药商。根据通用药品使用者费用修正案(GDUFA),未满足年费要求的其他印度公司包括Virupaksha Organics P. Ltd.,Vista Pharmaceuticals Ltd.和Vital Laboratories P.Ltd。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号